Akın Belli Aslı, Derviş Emine, Özbaş Gök Seyran, Midilli Kenan, Gargılı Ayşen
Mugla Sitki Kocman University Training and Research Hospital, Dermatology Clinic, Mugla, Turkey.
Mikrobiyol Bul. 2015 Oct;49(4):525-31.
Lyme disease (LD) is a tick-borne, multisystemic infection caused by Borrelia burgdorferi. Although variable rates of seropositivity for B.burgdorferi have been reported between 2% to 44% in Turkey, its actual prevalence is not well-understood. The aim of this retrospective study was to evaluate the characteristics of 10 cases of LD presenting as erythema migrans (EM) between 2009 and 2013 from Istanbul which is one of the metropolitan cities of Turkey. Of the patients, five were male and five were female, ages between 9-51 years (mean age: 34.5 years). Five of the patients were admitted in June, three in October, one in November and two in December and all have the history of tick bite in last 1-2 weeks. There were no clinical symptoms for systemic infection among the patients with normal level routine laboratory test (whole blood count and biochemical tests) results. Five of the cases had EM lesions in the trunk, three in the upper extremities, and two in the lower extremities. Four patients presented with annular, three with solitary macular, and three with target-like EM lesions. In all cases, the biopsy specimens were positive for B.burgdorferi sensu lato DNA with polymerase chain reaction and all were also positive in terms of B.burgdorferi IgM antibodies with ELISA. Nine patients were treated with oral doxycycline, 100 mg twice daily and one child patient was treated with oral amoxicillin 500 mg twice daily for 21 days. EM lesions disappeared within 2-4 weeks in all patients. There was no clinical evidence for systemic involvement in any of the patients like neurologic, cardiac, and joint involvement at the follow-ups on the third, sixth and 12(th) months. To our best knowledge, 10 patients in this study are the largest EM series reported from Turkey. The increase in the number of LD cases may be associated with increased tick bite and increased awareness due to the emergence of concurrent Crimean-Congo hemorrhagic fever epidemic in Turkey. As a result, when enlarged erythematous lesions on the skin were observed, LH must also be considered in differential diagnosis, history of tick bite should be questioned and etiological diagnostic test should be performed.
莱姆病(LD)是一种由伯氏疏螺旋体引起的蜱传播的多系统感染。尽管土耳其报告的伯氏疏螺旋体血清阳性率在2%至44%之间有所不同,但其实际患病率尚不清楚。这项回顾性研究的目的是评估2009年至2013年期间来自土耳其大都市之一伊斯坦布尔的10例表现为游走性红斑(EM)的莱姆病病例的特征。患者中,5例为男性,5例为女性,年龄在9至51岁之间(平均年龄:34.5岁)。5例患者于6月入院,3例于10月入院,1例于11月入院,2例于12月入院,所有患者在过去1至2周内均有蜱叮咬史。常规实验室检查(全血细胞计数和生化检查)结果正常的患者中没有全身感染的临床症状。5例病例的EM病变位于躯干,3例位于上肢,2例位于下肢。4例患者表现为环状,3例为孤立性斑疹,3例为靶样EM病变。在所有病例中,活检标本经聚合酶链反应检测伯氏疏螺旋体狭义DNA呈阳性,且经酶联免疫吸附测定伯氏疏螺旋体IgM抗体也均为阳性。9例患者接受口服强力霉素治疗,每日2次,每次100毫克,1例儿童患者接受口服阿莫西林治疗,每日2次,每次500毫克,持续21天。所有患者的EM病变在2至4周内消失。在第三个月、第六个月和第十二个月的随访中,没有任何患者出现神经系统、心脏和关节受累等全身受累的临床证据。据我们所知,本研究中的10例患者是土耳其报告的最大的EM病例系列。莱姆病病例数量的增加可能与蜱叮咬增加以及土耳其同时出现克里米亚-刚果出血热疫情导致的意识提高有关。因此,当观察到皮肤上出现扩大的红斑病变时,鉴别诊断中也必须考虑莱姆病,应询问蜱叮咬史并进行病因诊断测试。